Skip navigation

Establish Pricing, Reimbursement, Access, Distribution, Market Uptake and Success for New Therapies and Life Science Products

October 28-29, 2019
  • Boston, MA

In an increasingly complex healthcare landscape, it is more important than ever to have an early product launch plan for your drug. Whether you are a pre-commercial biotech or an established pharmaceutical company, you’ll face many of the same challenges as you prepare the market, prepare your organization and prepare your product for a successful launch.

Join us for CBI’s 5th Annual Bio/Pharmaceutical Product Launch Summit and analyze each necessary step to innovatively plan for a new product launch. Identify best practices, KPIs and “how to” tactics for immediate implementation.

Top Reasons to Attend:

  • Hear from experts on best practices for
    pre-commercialization planning
  • Optimize your post-launch infrastructure
  • Examine the differences between launching a rare
    disease drug, biosimilar, generic or specialty drug
  • Learn to navigate the risks and complexities involved in
    accurate budgeting and forecasting
  • Find inspiration from industry leaders on ways to create
    a clear, and concise communication platform for a
    drug candidate to improve performance
  • Take internal project management to the next level —
    build strategies to utilize across multiple departments
  • Delve into government pricing strategies as you
    prepare to go-to-market
  • Gain valuable insights on how to create a market research
    studies that support product launch activities
  • Prepare for market access strategies to propel your product launch
  • Draw from technology experts on ways to improve the serialization process, name creation and packaging design

Previous Attendee Acclaim:

I thought the conference was well prepared. All the speakers were experts in their topic and delivered their message effectively. Group interaction was also great. I learned a lot
and recommend this type of conference to anyone who is preparing to launch a product in the next 3-5 years.

Executive Director, Commercialization, Noven Pharmaceuticals

5th Annual Bio/Pharmaceutical Product Commercialization and Launch Roadmap

Establish Pricing, Reimbursement, Access, Distribution, Market Uptake and Success for New Therapies and Life Science Products

In an increasingly complex healthcare landscape, it is more important than ever to have an early product launch plan for your drug. Whether you are a pre-commercial biotech or an established pharmaceutical company, you’ll face many of the same challenges as you prepare the market, prepare your organization and prepare your product for a successful launch.

Join us for CBI’s 5th Annual Bio/Pharmaceutical Product Launch Summit and analyze each necessary step to innovatively plan for a new product launch. Identify best practices, KPIs and “how to” tactics for immediate implementation.

Top Reasons to Attend:

  • Hear from experts on best practices for
    pre-commercialization planning
  • Optimize your post-launch infrastructure
  • Examine the differences between launching a rare
    disease drug, biosimilar, generic or specialty drug
  • Learn to navigate the risks and complexities involved in
    accurate budgeting and forecasting
  • Find inspiration from industry leaders on ways to create
    a clear, and concise communication platform for a
    drug candidate to improve performance
  • Take internal project management to the next level —
    build strategies to utilize across multiple departments
  • Delve into government pricing strategies as you
    prepare to go-to-market
  • Gain valuable insights on how to create a market research
    studies that support product launch activities
  • Prepare for market access strategies to propel your product launch
  • Draw from technology experts on ways to improve the serialization process, name creation and packaging design

Previous Attendee Acclaim:

I thought the conference was well prepared. All the speakers were experts in their topic and delivered their message effectively. Group interaction was also great. I learned a lot
and recommend this type of conference to anyone who is preparing to launch a product in the next 3-5 years.

Executive Director, Commercialization, Noven Pharmaceuticals